Request a copy of the file

Enter the following information to request a copy for the following item: Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial.

Requesting the following file: 2019_Haddad_Oral_Oncol.pdf